ѧÊõÂÛÎĵIJο¼ÎÄÏ×µÄÖøÂ¼¸ñʽ
·¢²¼Ê±¼ä£º
2014-09-24
À´Ô´£º
ÈË´ó¾¼ÃÂÛ̳
1 ÆÚ¿¯ÎÄÕÂ
ÖøÂ¼¸ñʽ£ºÖ÷ÒªÔðÈÎÕß. ÌâÃû[ÎÄÏ×ÀàÐͱêÖ¾ÎÄÏ×ÔØÌå±êÖ¾]. ¿¯Ãû£¬ Ä꣬ ¾í(ÆÚ) ÆðÒ³-Ö¹Ò³[ÒýÓÃÈÕÆÚ]. »ñÈ¡ºÍ·ÃÎÊ·¾¶.
×¢£ºÎÄÏ×ÀàÐͱêÖ¾ÎÄÏ×ÔØÌå±ê־Ϊµç×ÓÎÄÏ×±ØÐëÖøÂ¼µÄÏîÄ¿£¬ÒýÓÃÈÕÆÚ¡¢»ñÈ¡ºÍ·ÃÎÊ·¾¶ÎªÁª»úÎÄÏ×±ØÐëÖøÂ¼µÄÏîÄ¿¡£
1.1 ÆÚ¿¯·Ö¾í£¬Á¬Ðø±àÒ³Âë»òÿÆÚµ¥¶À±àÒ³Âë
[1] Halpern SD£¬Ubel PA£¬Caplan AL. Solid-organ transplantation in
HIV-infected patients. N Engl J Med£¬2002£¬347(4) 284-287.
[2] ³ÂÃô»ª£¬ÎâÞ±£¬ÑîÞ±£¬µÈ. ³¬ÉùÔìÓ°¶Ô¸Î°©É䯵ÏûÈÚɸѡÊÊÓ¦Ö¤µÄÓ¦ÓüÛÖµ. ÖлªÒ½Ñ§ÔÓÖ¾£¬2005£¬85(49) 3491-3494.
[3] Íô¹ú»ª£¬Âí½ø£¬¼¾Êʶ«£¬µÈ. ¼±ÐÔ³öѪ»µËÀÐÔÒÈÏÙÑ×µÄÊÖÊõÖÎÁÆ. Öм¶Ò½¿¯£¬1995£¬30(8) 22-25.
1.2 ÆÚ¿¯²»·Ö¾í
[4] Turan I£¬Wredmark T£¬Fellander-Tsai L. Arthroscopic ankle arthrodesis in
rheumatoid arthritis. Clin Orthop£¬1995(320) 110-114.
1.3 ÆÚ¿¯ÎÞ¾íºÍÆÚ
[5] Browell DA£¬Lennard TW. Imunologic status of the cancer patients and
the effects of blood transfusion on antitumor responses. Curr Opin Gen
Surg£¬1993 325-333.
1.4 ¾íµÄÔö¿¯
[6] ÍôÏþÀ×£¬ÁèÏ飬Áõ×æË´. ¼ÒÍÃÃÔÂ·ÆÆ»µÑÛÕðµçͼÃè¼Ç. Öлª¶ú±ÇÑÊºí¿ÆÔÓÖ¾£¬1995£¬30Ôö¿¯ 13.
[7] Geraud G£¬Spierings EL£¬Keywood C. Tolerability and safety of
frovatriptan with short- and long-term use for treatment of migraine and
in comparison with sumatriptan. Headache£¬2002£¬42 Suppl 2 S93-99.
1.5 ¾íÖзֲ¿
[8] Abend SM£¬Kulish N. The psychoanalytic method from an epistemological
viewpoint. Int J Psychoanal£¬2002£¬83(Pt 2) 491-495.
1.6 ÆÚµÄÔö¿¯
[9] Glauser TA. Integrating clinical trial data into clinical practice.
Neurology£¬2002, 58(12 Suppl 7) S6-12.
1.7 ÆÚÖзֲá
[10] Ahrar K£¬Madoff DC£¬Gupta S£¬et al. Development of a large animal model
for lung tumors. J Vasc Interv Radiol£¬2002£¬13(9 Pt 1) 923-928.
1.8 Á½ÆÚºÏÆÚ
[11] Rose ME£¬Huerbin MB£¬Melick J£¬et al. Regulation of interstitial
excitatory amino acid concentrations after cortical contusion injury.
Brain Res£¬2002£¬935(12) 40-46.
1.9 ¼¯Ìå×÷Õß
[12] Diabetes Prevention Program Research Group. Hypertension£¬insulin£¬and
proinsulin in participants with impaired glucose tolerance.
Hypertension£¬2002, 40(5) 679-686.
[13] ÖлªÒ½Ñ§»á¼ìÑéҽѧ·Ö»á. ¼ìÑé¿ÆÑÏÖØ¼±ÐÔºôÎü×ÛºÏÕ÷±ê±¾¼ì²â°²È«¹ÜÀíÖ¸ÄÏ(ÔÝÐÐ). Öлª¼ìÑéҽѧÔÓÖ¾£¬2003£¬26(5)
320-321.
1.10 ×÷ÕßδÊðÃû
[14] 21st century heart solution may have a sting in the tail.
BMJ£¬2002£¬325(7357) 184.
1.11 ͬһÆÚ¿¯Á¬ÔØ
[15] ±±¾©ÊмìÑéѧ»á¼ÌÐø½ÌÓýίԱ»á. ÁÙ´²ÃâÒßѧ¼ìÑéÁ·Ï°Ìâ. Öлª¼ìÑéҽѧÔÓÖ¾£¬2002£¬25(5) 314-315;2002£¬25(6)
379-381.
1.12 µç×ÓÆÚ¿¯
[16] Abood S. Quality improvement initiative in nursing homes the ANA
acts in an advisory role[JOL]. Am J Nurs£¬2002£¬102(6)23[2002-08-12].
http://www.nursingworld.org/AJN2002juneWawatch.htm.
[17] ĪÉÙÇ¿. Êý×ÖʽÖÐÎÄÈ«ÎÄÎÄÏ׸ñʽµÄÉè¼ÆÓëÑо¿[JOL]. Ç鱨ѧ±¨£¬1999£¬18(4)1-6[2001-07-08].
http://periodical.wanfangdata.com.cn/periodical
qbxbqbxb99qbxb9904990407.htm.
[18] Íõ•D£¬ÓÚÏþÁᣬ³ÌÖ¾¸Õ. ¸ÎÔàÑ×ÐÔ¼ÙÁöµÄ³¬ÉùÔìÓ°±íÏÖ[JCD]. ÖлªÒ½Ñ§³¬ÉùÔÓÖ¾ µç×Ó°æ, 2006, 3(1).
1.13 ÒëÎÄ
[19] Kinra S£¬Lewendon G£¬Nelder R£¬et al. »¯Ñ§ÆøÌåÎÛȾͻ·¢Ê¼þÖеÄÈËȺÊèÉ¢ ºá¶ÏÃæµ÷²é. ³ÂÀ×£¬Òë.
Ó¢¹úҽѧÔÓÖ¾ÖÐÎİ棬2005£¬8(5) 285-288.
2 ÆÕͨͼÊé
2.1 Öø×÷»ò±àÖø
ÖøÂ¼¸ñʽ£ºÖ÷ÒªÔðÈÎÕß. ÌâÃûÆäËûÌâÃûÐÅÏ¢[ÎÄÏ×ÀàÐͱêÖ¾ÎÄÏ×ÔØÌå±êÖ¾]. ÆäËûÔðÈÎÕß(ÀýÈç·ÒëÕß). °æ±¾Ïî(µÚ1°æ²»ÖøÂ¼). ³ö°æµØ
³ö°æÕߣ¬³ö°æÄê ÒýÎÄÆðÒ³-Ö¹Ò³[ÒýÓÃÈÕÆÚ]. »ñÈ¡ºÍ·ÃÎÊ·¾¶.
×¢£ºÎÄÏ×ÀàÐͱêÖ¾ÎÄÏ×ÔØÌå±ê־Ϊµç×ÓÎÄÏ×±ØÐëÖøÂ¼µÄÏîÄ¿£¬ÒýÓÃÈÕÆÚ¡¢»ñÈ¡ºÍ·ÃÎÊ·¾¶ÎªÁª»úÎÄÏ×±ØÐëÖøÂ¼µÄÏîÄ¿¡£
[20] Íõ¼ÒÁ¼. ÁÙ´²Á÷Ðв¡Ñ§ ÁÙ´²¿ÆÑÐÉè¼Æ¡¢ºâÁ¿ÓëÆÀ¼Û. 2°æ. ÉϺ£ÉϺ£¿ÆÑ§¼¼Êõ³ö°æÉ磬2001.
[21] Îâ½×ƽ£¬Ï®·¨×æ. »Æ¼ÒæáÍâ¿ÆÑ§. 6°æ. ±±¾© ÈËÃñÎÀÉú³ö°æÉ磬2002.
[22] Murray PR£¬Rosenthal KS£¬Kobayashi GS£¬et al. Medical microbiology. 4th
ed. St. Louis Mosby£¬2002.
[23] ºö˼»Û. ÒûÉÅÕýÒª. Ó°Ó¡Ã÷¿Ì±¾. ÉϺ£ ÉϺ£¹Å¼®³ö°æÉ磬1990.
[24] Íõ·òÖ®. ËÎÂÛ. ¿Ì±¾. ½ðÁê ÔøÊÏ£¬1865(ÇåͬÖÎËÄÄê).
[25] Abrams WB£¬Beers MH£¬Berkow R. Ĭ¿ËÀÏÄ겡ÊÖ²á. ³Âå°Ö飬ÍõÔÞË´£¬ÁõºñîÚ£¬µÈ£¬Òë. 2°æ. ±±¾©
ÈËÃñÎÀÉú³ö°æÉ磬1996 22-25.
[26] ÕÔÒ«¶«. ÐÂʱ´úµÄ¹¤Òµ¹¤³Ìʦ[MOL]. ̨±± ÌìÏÂÎÄ»¯³ö°æÉ磬1998[1998-09-26].
http://www.ie.nthu.edu.tw/infoie.newie.htm(Big5).
[27] Foley KM£¬Gelband H. Improving palliative care for cancer [MOL].
Washington National Academy Press£¬2001 [2002-07-09].
http://www.nap.edu/books0309074029html.
[28] ÁÖ½ÌÎ. Ö§Æø¹ÜÏø´µÄÕï¶ÏÓëÖÎÁÆ[MDK]. ±±¾© ÖлªÒ½Ñ§µç×ÓÒôÏñ³ö°æÉ磬2005.
[29] ±±¾©ÊÐÉñ¾Íâ¿ÆÑо¿Ëù.ÍõÖÒ³ÏÉñ¾Íâ¿ÆÊÖÊõѧÊõϵÁжàýÌå½Ì³Ì[MCD]. ±±¾© ÖлªÒ½Ñ§µç×ÓÒôÏñ³ö°æÉ磬2001.
2.2 Îö³öÎÄÏ×
ÖøÂ¼¸ñʽ£ºÎö³öÎÄÏ×Ö÷ÒªÔðÈÎÕß. Îö³öÎÄÏ×ÌâÃû[ÎÄÏ×ÀàÐͱêÖ¾ÎÄÏ×ÔØÌå±êÖ¾] ׍ָÖ÷ÒªÔðÈÎÕß. ׍ָÌâÃû ÆäËûÌâÃûÐÅÏ¢.
°æ±¾Ïî(µÚ1°æ²»ÖøÂ¼). ³ö°æµØ ³ö°æÕߣ¬³ö°æÄê Îö³öÎÄÏׯðÒ³-Ö¹Ò³[ÒýÓÃÈÕÆÚ]. »ñÈ¡ºÍ·ÃÎÊ·¾¶.
×¢£ºÎÄÏ×ÀàÐͱêÖ¾ÎÄÏ×ÔØÌå±ê־Ϊµç×ÓÎÄÏ×±ØÐëÖøÂ¼µÄÏîÄ¿£¬ÒýÓÃÈÕÆÚ¡¢»ñÈ¡ºÍ·ÃÎÊ·¾¶ÎªÁª»úÎÄÏ×±ØÐëÖøÂ¼µÄÏîÄ¿¡£
[30] Öî¿¥ÈÊ. »èØÊÓëÐݿ˶³ÐÀÅ£¬ÌÕÊÙä¿£¬³Âå°Öé. ʵÓÃÐÄÔಡѧ. 3 °æ. ÉϺ£ÉϺ£¿ÆÑ§¼¼Êõ³ö°æÉ磬1993 561-585.
[31] Meltzer PS£¬Kallioniemi A£¬Trent JM. Chromosome alterations in human
solid tumorsVogelstein B£¬Kinzler KW. The genetic basis of human cancer.
New York McGraw-Hill£¬2002 93-113.
[32] µËСƽ. ¿ÆÑ§¼¼ÊõÊǵÚÒ»Éú²úÁ¦µËСƽ. µËСƽÎÄÑ¡µÚ3¾í. ±±¾© ÈËÃñ³ö°æÉ磬1993 274-276.
[33] ³Â±ë. ÅÁ½ðɲ¡[MCD] ¼Ö½¨Æ½£¬ÕÅÐÂÇä. Éñ¾ÏµÍ³¼²²¡ÕïÖνøÕ¹. ±±¾© ÖлªÒ½Ñ§µç×ÓÒôÏñ³ö°æÉ磬2005.
[34] Anderson SC£¬Poulsen KB. Andersons electronic atlas of hematology
[MCD]. Philadelphia Lippincott Williams & Wilkins£¬2002.
3 »áÒéÎÄÏ×